{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:40:34Z","timestamp":1789065634036,"version":"build-2803163510"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1013141"],"award-info":[{"award-number":["2022R1A2C1013141"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C1090251"],"award-info":[{"award-number":["2019R1A2C1090251"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1C1C1005080"],"award-info":[{"award-number":["2022R1C1C1005080"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1013141"],"award-info":[{"award-number":["2022R1A2C1013141"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1C1C1005080"],"award-info":[{"award-number":["2022R1C1C1005080"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C1090251"],"award-info":[{"award-number":["2019R1A2C1090251"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1013141"],"award-info":[{"award-number":["2022R1A2C1013141"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["A0433-20230100"],"award-info":[{"award-number":["A0433-20230100"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["A0433-20230100"],"award-info":[{"award-number":["A0433-20230100"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011017","name":"Recherches Scientifiques Luxembourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006672","name":"Action LIONS Vaincre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006672","id-type":"DOI","asserted-by":"publisher"}]},{"name":"T\u00e9l\u00e9vie Luxembourg"},{"DOI":"10.13039\/501100011691","name":"Fondation\u00a0Recherche Cancer et Sang","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00220628"],"award-info":[{"award-number":["RS-2023-00220628"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00220628"],"award-info":[{"award-number":["RS-2023-00220628"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute myeloid leukemia (AML) is a highly aggressive cancer with a 5-year survival rate of less than 35%. It is characterized by significant drug resistance and abnormal energy metabolism. Mitochondrial dynamics and metabolism are crucial for AML cell survival. Mitochondrial fusion protein optic atrophy (OPA)1 is upregulated in AML patients with adverse mutations and correlates with poor prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This study investigated targeting OPA1 with TMQ0153, a tetrahydrobenzimidazole derivative, to disrupt mitochondrial metabolism and dynamics as a novel therapeutic approach to overcome treatment resistance. Effects of TMQ0153 treatment on OPA1 and mitofusin (MFN)2 protein levels, mitochondrial morphology, and function in AML cells. In this study, we examined reactive oxygen species (ROS) production, oxidative phosphorylation (OXPHOS) inhibition, mitochondrial membrane potential (MMP) depolarization, and apoptosis. Additionally, metabolic profiling was conducted to analyze changes in metabolic pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TMQ0153 treatment significantly reduced OPA1 and mitofusin (MFN)2 protein levels and disrupted the mitochondrial morphology and function in AML cells. This increases ROS production and inhibits OXPHOS, MMP depolarization, and caspase-dependent apoptosis. Metabolic reprogramming was observed, shifting from mitochondrial respiration to glycolysis and impaired respiratory chain activity. Profiling revealed reduced overall metabolism along with changes in the glutathione (GSH)\/oxidized glutathione (GSSG) and NAD\u207a\/NADH redox ratios. TMQ0153 treatment reduces tumor volume and weight in MV4-11 xenografts in vivo. Combination therapies with TMQ0153 and other AML drugs significantly reduced the leukemic burden and prolonged survival in NOD scid gamma (NSG) mice xenografted with U937-luc and MOLM-14-luc cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TMQ0153 targets mitochondrial dynamics by inhibiting OPA1, inducing metabolic reprogramming, and triggering apoptosis in AML cells. It enhances the efficacy of existing AML therapies and provides a promising combination treatment approach that exploits mitochondrial vulnerability and metabolic reprogramming to improve treatment outcomes in AML.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03372-0","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T03:15:54Z","timestamp":1743995754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tetrahydrobenzimidazole TMQ0153 targets OPA1 and restores drug sensitivity in AML via ROS-induced mitochondrial metabolic reprogramming"],"prefix":"10.1186","volume":"44","author":[{"given":"Su Jung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cerella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Mo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Orlikova-Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lorant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schnekenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al-Mourabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christo","family":"Christov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Woo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Diederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"3","key":"3372_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453\u201374.","journal-title":"Blood"},{"issue":"8","key":"3372_CR2","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.drudis.2022.04.013","volume":"27","author":"A Sarkar","year":"2022","unstructured":"Sarkar A, Jayesh Sodha S, Junnuthula V, Kolimi P, Dyawanapelly S. Novel and investigational therapies for wet and dry age-related macular degeneration. Drug Discov Today. 2022;27(8):2322\u201332.","journal-title":"Drug Discov Today"},{"issue":"1","key":"3372_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2196482","volume":"28","author":"MZ Mohamed Jiffry","year":"2023","unstructured":"Mohamed Jiffry MZ, Kloss R, Ahmed-Khan M, Carmona-Pires F, Okam N, Weeraddana P, Dharmaratna D, Dandwani M, Moin K. A review of treatment options employed in relapsed\/refractory AML. Hematology. 2023;28(1): 2196482.","journal-title":"Hematology"},{"issue":"7","key":"3372_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, Bosc C, Sugita M, Stuani L, Fraisse M, et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 2017;7(7):716\u201335.","journal-title":"Cancer Discov"},{"key":"3372_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.leukres.2017.09.021","volume":"62","author":"K Henkenius","year":"2017","unstructured":"Henkenius K, Greene BH, Barckhausen C, Hartmann R, Marken M, Kaiser T, Rehberger M, Metzelder SK, Parak WJ, Neubauer A, et al. Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia. Leuk Res. 2017;62:56\u201363.","journal-title":"Leuk Res"},{"issue":"1","key":"3372_CR6","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1038\/s41467-020-17882-2","volume":"11","author":"C Bosc","year":"2020","unstructured":"Bosc C, Broin N, Fanjul M, Saland E, Farge T, Courdy C, Batut A, Masoud R, Larrue C, Skuli S, et al. Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites. Nat Commun. 2020;11(1):4056.","journal-title":"Nat Commun"},{"issue":"3","key":"3372_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/carcin\/bgt480","volume":"35","author":"TN Seyfried","year":"2014","unstructured":"Seyfried TN, Flores RE, Poff AM, D\u2019Agostino DP. Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis. 2014;35(3):515\u201327.","journal-title":"Carcinogenesis"},{"issue":"1","key":"3372_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pages M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11\u201331.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"3372_CR9","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3390\/jcm8111983","volume":"8","author":"L Moro","year":"2019","unstructured":"Moro L. Mitochondrial dysfunction in aging and cancer. J Clin Med. 2019;8(11):1983.","journal-title":"J Clin Med"},{"key":"3372_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ceb.2020.08.014","volume":"68","author":"AR Fenton","year":"2021","unstructured":"Fenton AR, Jongens TA, Holzbaur ELF. Mitochondrial dynamics: Shaping and remodeling an organelle network. Curr Opin Cell Biol. 2021;68:28\u201336.","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"3372_CR11","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100067R","volume":"35","author":"M Adebayo","year":"2021","unstructured":"Adebayo M, Singh S, Singh AP, Dasgupta S. Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis. FASEB J. 2021;35(6): e21620.","journal-title":"FASEB J"},{"issue":"8","key":"3372_CR12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/eci.12135","volume":"43","author":"L Scorrano","year":"2013","unstructured":"Scorrano L. Keeping mitochondria in shape: a matter of life and death. Eur J Clin Invest. 2013;43(8):886\u201393.","journal-title":"Eur J Clin Invest"},{"issue":"22","key":"3372_CR13","doi-asserted-by":"publisher","first-page":"13880","DOI":"10.3390\/ijms232213880","volume":"23","author":"S Guan","year":"2022","unstructured":"Guan S, Zhao L, Peng R. Mitochondrial respiratory chain supercomplexes: from structure to function. Int J Mol Sci. 2022;23(22):13880.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3372_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2013.08.032","volume":"155","author":"S Cogliati","year":"2013","unstructured":"Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R, Corrado M, Cipolat S, Costa V, Casarin A, Gomes LC, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell. 2013;155(1):160\u201371.","journal-title":"Cell"},{"issue":"1","key":"3372_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1534-5807(01)00116-2","volume":"2","author":"L Scorrano","year":"2002","unstructured":"Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA, Korsmeyer SJ. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell. 2002;2(1):55\u201367.","journal-title":"Dev Cell"},{"issue":"11","key":"3372_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc3803","volume":"14","author":"SS Sabharwal","year":"2014","unstructured":"Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel? Nat Rev Cancer. 2014;14(11):709\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3372_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2014.03.011","volume":"19","author":"P Mishra","year":"2014","unstructured":"Mishra P, Carelli V, Manfredi G, Chan DC. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metab. 2014;19(4):630\u201341.","journal-title":"Cell Metab"},{"issue":"Pt 26","key":"3372_CR18","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.1242\/jcs.01565","volume":"117","author":"N Ishihara","year":"2004","unstructured":"Ishihara N, Eura Y, Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci. 2004;117(Pt 26):6535\u201346.","journal-title":"J Cell Sci"},{"issue":"6","key":"3372_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/embor.2011.54","volume":"12","author":"CS Palmer","year":"2011","unstructured":"Palmer CS, Osellame LD, Laine D, Koutsopoulos OS, Frazier AE, Ryan MT. MiD49 and MiD51, new components of the mitochondrial fission machinery. Embo Rep. 2011;12(6):565\u201373.","journal-title":"Embo Rep"},{"issue":"15","key":"3372_CR20","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1128\/MCB.23.15.5409-5420.2003","volume":"23","author":"Y Yoon","year":"2003","unstructured":"Yoon Y, Krueger EW, Oswald BJ, McNiven MA. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol. 2003;23(15):5409\u201320.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"3372_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41419-023-05768-2","volume":"14","author":"M Noguchi","year":"2023","unstructured":"Noguchi M, Kohno S, Pellattiero A, Machida Y, Shibata K, Shintani N, Kohno T, Gotoh N, Takahashi C, Hirao A, et al. Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinomaresistant cell line. Cell Death Dis. 2023;14(4):241.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3372_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cmet.2020.04.007","volume":"31","author":"S Herkenne","year":"2020","unstructured":"Herkenne S, Ek O, Zamberlan M, Pellattiero A, Chergova M, Chivite I, Novotna E, Rigoni G, Fonseca TB, Samardzic D, et al. Developmental and tumor angiogenesis requires the mitochondria-shaping protein Opa1. Cell Metab. 2020;31(5):987-1003 e1008.","journal-title":"Cell Metab"},{"key":"3372_CR23","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1146\/annurev.bi.54.070185.005055","volume":"54","author":"Y Hatefi","year":"1985","unstructured":"Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem. 1985;54:1015\u201369.","journal-title":"Annu Rev Biochem"},{"key":"3372_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2018.05.006","volume":"47","author":"K Yaku","year":"2018","unstructured":"Yaku K, Okabe K, Nakagawa T. NAD metabolism: implications in aging and longevity. Ageing Res Rev. 2018;47:1\u201317.","journal-title":"Ageing Res Rev"},{"key":"3372_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00622","volume":"8","author":"K Yaku","year":"2018","unstructured":"Yaku K, Okabe K, Hikosaka K, Nakagawa T. NAD metabolism in cancer therapeutics. Front Oncol. 2018;8: 622.","journal-title":"Front Oncol"},{"issue":"5","key":"3372_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034525","volume":"7","author":"F Sun","year":"2012","unstructured":"Sun F, Dai C, Xie J, Hu X. Biochemical issues in estimation of cytosolic free NAD\/NADH ratio. PLoS ONE. 2012;7(5): e34525.","journal-title":"PLoS ONE"},{"issue":"3191","key":"3372_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309\u201314.","journal-title":"Science"},{"issue":"8","key":"3372_CR28","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1038\/s41375-022-01614-0","volume":"36","author":"SB Panina","year":"2022","unstructured":"Panina SB, Pei J, Baran N, Tjahjono E, Patel S, Alatrash G, Konoplev S, Stolbov LA, Poroikov VV, Konopleva M, et al. Novel mitochondria-targeting compounds selectively kill human leukemia cells. Leukemia. 2022;36(8):2009\u201321.","journal-title":"Leukemia"},{"key":"3372_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102814","volume":"144","author":"K Mattes","year":"2019","unstructured":"Mattes K, Vellenga E, Schepers H. Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy. Crit Rev Oncol Hematol. 2019;144: 102814.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"3372_CR30","doi-asserted-by":"publisher","first-page":"20829","DOI":"10.1002\/jcp.28688","volume":"234","author":"P Riccio","year":"2019","unstructured":"Riccio P, Sessa R, de Nicola S, Petruzziello F, Trombetti S, Menna G, Pepe G, Maddalena P, Izzo P, Grosso M. GATA-1 isoforms differently contribute to the production and compartmentation of reactive oxygen species in the myeloid leukemia cell line K562. J Cell Physiol. 2019;234(11):20829\u201346.","journal-title":"J Cell Physiol"},{"issue":"5","key":"3372_CR31","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3390\/ijms22052470","volume":"22","author":"S Trombetti","year":"2021","unstructured":"Trombetti S, Cesaro E, Catapano R, Sessa R, Lo Bianco A, Izzo P, Grosso M. Oxidative stress and ROS-mediated signaling in leukemia: novel promising perspectives to eradicate chemoresistant cells in myeloid leukemia. Int J Mol Sci. 2021;22(5):2470.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3372_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/mco.2017.1129","volume":"6","author":"A Nicolussi","year":"2017","unstructured":"Nicolussi A, D\u2019Inzeo S, Capalbo C, Giannini G, Coppa A. The role of peroxiredoxins in cancer. Mol Clin Oncol. 2017;6(2):139\u201353.","journal-title":"Mol Clin Oncol"},{"key":"3372_CR33","doi-asserted-by":"publisher","first-page":"6175804","DOI":"10.1155\/2019\/6175804","volume":"2019","author":"AV Snezhkina","year":"2019","unstructured":"Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS, Dmitriev AA. ROS generation and antioxidant defense systems in normal and malignant cells. Oxid Med Cell Longev. 2019;2019:6175804.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"3372_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40364-020-00242-z","volume":"8","author":"NM Kaweme","year":"2020","unstructured":"Kaweme NM, Zhou S, Changwe GJ, Zhou F. The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applications. Biomark Res. 2020;8(1):63.","journal-title":"Biomark Res"},{"issue":"3","key":"3372_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/sj.cdd.4400959","volume":"9","author":"JS Armstrong","year":"2002","unstructured":"Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Knox SJ. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ. 2002;9(3):252\u201363.","journal-title":"Cell Death Differ"},{"key":"3372_CR36","doi-asserted-by":"publisher","first-page":"1341604","DOI":"10.1155\/2021\/1341604","volume":"2021","author":"BJ Foo","year":"2021","unstructured":"Foo BJ, Eu JQ, Hirpara JL, Pervaiz S. Interplay between mitochondrial metabolism and cellular redox state dictates cancer cell survival. Oxid Med Cell Longev. 2021;2021:1341604.","journal-title":"Oxid Med Cell Longev"},{"key":"3372_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fphar.2014.00151","volume":"5","author":"V Ribas","year":"2014","unstructured":"Ribas V, Garcia-Ruiz C, Fernandez-Checa JC. Glutathione and mitochondria. Front Pharmacol. 2014;5:151.","journal-title":"Front Pharmacol"},{"issue":"42","key":"3372_CR38","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1002\/ejoc.201801077","volume":"2018","author":"MQ Tran","year":"2018","unstructured":"Tran MQ, Nguyen TB, Sawadogo WR, Ermolenko L, Song S, Retailleau P, Diederich M, Al-Mourabit A. Unaromatized tetrahydrobenzimidazole synthesis from p-benzoquinone and n-arylamidines and their cytotoxic potential. Eur J Org Chem. 2018;2018(42):5878\u201384.","journal-title":"Eur J Org Chem"},{"issue":"4","key":"3372_CR39","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1073\/pnas.53.4.703","volume":"53","author":"H Lundegardh","year":"1965","unstructured":"Lundegardh H. The Influence of Diuron (3-(3,4-Dichlorophenyl)-1,1-Dimethylurea) on the respiratory and photosynthetic systems of plants. Proc Natl Acad Sci U S A. 1965;53(4):703\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3372_CR40","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1515\/znc-1984-0511","volume":"39","author":"WFJ Vermaas","year":"1984","unstructured":"Vermaas WFJ, Renger G, Arntzen CJ. Herbicide quinone binding interactions in photosystem-Ii. Zeitschrift Fur Naturforschung C-a Journal of Biosciences. 1984;39(5):368\u201373.","journal-title":"Zeitschrift Fur Naturforschung C-a Journal of Biosciences"},{"issue":"2","key":"3372_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41419-020-2304-8","volume":"11","author":"S Song","year":"2020","unstructured":"Song S, Lee JY, Ermolenko L, Mazumder A, Ji S, Ryu H, Kim H, Kim DW, Lee JW, Dicato M, et al. Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia. Cell Death Dis. 2020;11(2):109.","journal-title":"Cell Death Dis"},{"key":"3372_CR42","doi-asserted-by":"crossref","unstructured":"Bartha A, Gyorffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22(5):2622.","DOI":"10.3390\/ijms22052622"},{"issue":"W1","key":"3372_CR43","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"3372_CR44","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","volume":"28","author":"T Haferlach","year":"2010","unstructured":"Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Bene MC, De Vos J, Hernandez JM, Hofmann WK, Mills KI, et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol. 2010;28(15):2529\u201337.","journal-title":"J Clin Oncol"},{"issue":"D1","key":"3372_CR45","doi-asserted-by":"publisher","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","volume":"44","author":"FO Bagger","year":"2016","unstructured":"Bagger FO, Sasivarevic D, Sohi SH, Laursen LG, Pundhir S, Sonderby CK, Winther O, Rapin N, Porse BT. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 2016;44(D1):D917-924.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3372_CR46","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","volume":"40","author":"D Bottomly","year":"2022","unstructured":"Bottomly D, Long N, Schultz AR, Kurtz SE, Tognon CE, Johnson K, Abel M, Agarwal A, Avaylon S, Benton E, et al. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell. 2022;40(8):850-864 e859.","journal-title":"Cancer Cell"},{"issue":"8","key":"3372_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41408-018-0103-6","volume":"8","author":"M Marquis","year":"2018","unstructured":"Marquis M, Beaubois C, Lavallee VP, Abrahamowicz M, Danieli C, Lemieux S, Ahmad I, Wei A, Ting SB, Fleming S, et al. High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia. Blood Cancer J. 2018;8(8):68.","journal-title":"Blood Cancer J"},{"issue":"6","key":"3372_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.36","volume":"6","author":"A Maiga","year":"2016","unstructured":"Maiga A, Lemieux S, Pabst C, Lavallee VP, Bouvier M, Sauvageau G, Hebert J. Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets. Blood Cancer J. 2016;6(6): e431.","journal-title":"Blood Cancer J"},{"issue":"6","key":"3372_CR49","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41375-018-0069-1","volume":"32","author":"VP Lavallee","year":"2018","unstructured":"Lavallee VP, Chagraoui J, MacRae T, Marquis M, Bonnefoy A, Krosl J, Lemieux S, Marinier A, Pabst C, Rivard GE, et al. Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin. Leukemia. 2018;32(6):1349\u201357.","journal-title":"Leukemia"},{"issue":"4","key":"3372_CR50","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.immuni.2021.03.001","volume":"54","author":"G Ehx","year":"2021","unstructured":"Ehx G, Larouche JD, Durette C, Laverdure JP, Hesnard L, Vincent K, Hardy MP, Theriault C, Rulleau C, Lanoix J, et al. Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes. Immunity. 2021;54(4):737-752 e710.","journal-title":"Immunity"},{"issue":"1","key":"3372_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","volume":"36","author":"I Baccelli","year":"2019","unstructured":"Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella JF, Corneau S, Mayotte N, Girard S, Frechette M, Blouin-Chagnon V, et al. Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia. Cancer Cell. 2019;36(1):84-99 e88.","journal-title":"Cancer Cell"},{"issue":"1","key":"3372_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41375-023-02076-8","volume":"38","author":"C Cerella","year":"2024","unstructured":"Cerella C, Gajulapalli SR, Lorant A, Gerard D, Muller F, Lee Y, Kim KR, Han BW, Christov C, Recher C, et al. ATP1A1\/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides. Leukemia. 2024;38(1):67\u201381.","journal-title":"Leukemia"},{"issue":"2","key":"3372_CR53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249\u201364.","journal-title":"Biostatistics"},{"issue":"1","key":"3372_CR54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40170-021-00253-w","volume":"9","author":"SB Panina","year":"2021","unstructured":"Panina SB, Pei J, Kirienko NV. Mitochondrial metabolism as a target for acute myeloid leukemia treatment. Cancer Metab. 2021;9(1):17.","journal-title":"Cancer Metab"},{"issue":"1","key":"3372_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8(1):333.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3372_CR56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369\u201379.","journal-title":"Cell Death Differ"},{"key":"3372_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ceb.2015.02.001","volume":"33","author":"M Roy","year":"2015","unstructured":"Roy M, Reddy PH, Iijima M, Sesaki H. Mitochondrial division and fusion in metabolism. Curr Opin Cell Biol. 2015;33:111\u20138.","journal-title":"Curr Opin Cell Biol"},{"key":"3372_CR58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mito.2019.11.006","volume":"51","author":"S Jang","year":"2020","unstructured":"Jang S, Javadov S. OPA1 regulates respiratory supercomplexes assembly: The role of mitochondrial swelling. Mitochondrion. 2020;51:30\u20139.","journal-title":"Mitochondrion"},{"issue":"5","key":"3372_CR59","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cmet.2017.10.013","volume":"26","author":"C Bosc","year":"2017","unstructured":"Bosc C, Selak MA, Sarry JE. Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment. Cell Metab. 2017;26(5):705\u20137.","journal-title":"Cell Metab"},{"issue":"11","key":"3372_CR60","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","volume":"2","author":"C Bosc","year":"2021","unstructured":"Bosc C, Saland E, Bousard A, Gadaud N, Sabatier M, Cognet G, Farge T, Boet E, Gotanegre M, Aroua N, et al. Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia. Nat Cancer. 2021;2(11):1204\u201323.","journal-title":"Nat Cancer"},{"issue":"7","key":"3372_CR61","doi-asserted-by":"publisher","first-page":"e201907098","DOI":"10.1083\/jcb.201907098","volume":"219","author":"C Yu","year":"2020","unstructured":"Yu C, Zhao J, Yan L, Qi Y, Guo X, Lou Z, Hu J, Rao Z. Structural insights into G domain dimerization and pathogenic mutation of OPA1. J Cell Biol. 2020;219(7):e201907098.","journal-title":"J Cell Biol"},{"issue":"41","key":"3372_CR62","doi-asserted-by":"publisher","first-page":"16553","DOI":"10.1021\/ja205962b","volume":"133","author":"RJ O'Reilly","year":"2011","unstructured":"O\u2019Reilly RJ, Chan B, Taylor MS, Ivanic S, Bacskay GB, Easton CJ, Radom L. Hydrogen abstraction by chlorine atom from amino acids: remarkable influence of polar effects on regioselectivity. J Am Chem Soc. 2011;133(41):16553\u20139.","journal-title":"J Am Chem Soc"},{"issue":"10","key":"3372_CR63","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1039\/C7SC04905F","volume":"9","author":"K Kumar","year":"2018","unstructured":"Kumar K, Woo SM, Siu T, Cortopassi WA, Duarte F, Paton RS. Cation-pi interactions in protein-ligand binding: theory and data-mining reveal different roles for lysine and arginine. Chem Sci. 2018;9(10):2655\u201365.","journal-title":"Chem Sci"},{"issue":"3","key":"3372_CR64","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.stemcr.2018.01.005","volume":"10","author":"ML Rasmussen","year":"2018","unstructured":"Rasmussen ML, Kline LA, Park KP, Ortolano NA, Romero-Morales AI, Anthony CC, Beckermann KE, Gama V. A Non-apoptotic Function of MCL-1 in Promoting Pluripotency and Modulating Mitochondrial Dynamics in Stem Cells. Stem Cell Rep. 2018;10(3):684\u201392.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"3372_CR65","doi-asserted-by":"publisher","first-page":"13902","DOI":"10.1038\/s41598-018-32308-2","volume":"8","author":"F Salehi","year":"2018","unstructured":"Salehi F, Behboudi H, Kavoosi G, Ardestani SK. Oxidative DNA damage induced by ROS-modulating agents with the ability to target DNA: A comparison of the biological characteristics of citrus pectin and apple pectin. Sci Rep. 2018;8(1):13902.","journal-title":"Sci Rep"},{"issue":"3","key":"3372_CR66","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/ars.2017.7415","volume":"30","author":"JM Berthiaume","year":"2019","unstructured":"Berthiaume JM, Kurdys JG, Muntean DM, Rosca MG. Mitochondrial NAD(+)\/NADH Redox State and Diabetic Cardiomyopathy. Antioxid Redox Signal. 2019;30(3):375\u201398.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"3372_CR67","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/ars.2007.1672","volume":"10","author":"W Ying","year":"2008","unstructured":"Ying W. NAD+\/NADH and NADP+\/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal. 2008;10(2):179\u2013206.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3372_CR68","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/s41467-022-29639-0","volume":"13","author":"A Erdem","year":"2022","unstructured":"Erdem A, Marin S, Pereira-Martins DA, Geugien M, Cunningham A, Pruis MG, Weinhauser I, Gerding A, Bakker BM, Wierenga ATJ, et al. Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability. Nat Commun. 2022;13(1):2013.","journal-title":"Nat Commun"},{"issue":"1","key":"3372_CR69","doi-asserted-by":"publisher","first-page":"13301","DOI":"10.1038\/s41598-018-31489-0","volume":"8","author":"S Wu","year":"2018","unstructured":"Wu S, Akhtari M, Alachkar H. Characterization of Mutations in the Mitochondrial Encoded Electron Transport Chain Complexes in Acute Myeloid Leukemia. Sci Rep. 2018;8(1):13301.","journal-title":"Sci Rep"},{"issue":"7","key":"3372_CR70","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","volume":"9","author":"T Nechiporuk","year":"2019","unstructured":"Nechiporuk T, Kurtz SE, Nikolova O, Liu T, Jones CL, D\u2019Alessandro A, Culp-Hill R, d\u2019Almeida A, Joshi SK, Rosenberg M, et al. The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov. 2019;9(7):910\u201325.","journal-title":"Cancer Discov"},{"issue":"12","key":"3372_CR71","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M, D\u2019Alessandro A, Culp-Hill R, Riemondy KA, Gillen AE, et al. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018;24(12):1859\u201366.","journal-title":"Nat Med"},{"issue":"12","key":"3372_CR72","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.stem.2024.09.008","volume":"31","author":"G Han","year":"2024","unstructured":"Han G, Cui M, Lu P, Zhang T, Yin R, Hu J, Chai J, Wang J, Gao K, Liu W, et al. Selective translation of nuclear mitochondrial respiratory proteins reprograms succinate metabolism in AML development and chemoresistance. Cell Stem Cell. 2024;31(12):1777-1793 e1779.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"3372_CR73","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.3390\/ijms19103198","volume":"19","author":"D Staudt","year":"2018","unstructured":"Staudt D, Murray HC, McLachlan T, Alvaro F, Enjeti AK, Verrills NM, Dun MD. Targeting oncogenic signaling in mutant FLT3 acute myeloid leukemia: the path to least resistance. Int J Mol Sci. 2018;19(10):3198.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3372_CR74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11864-017-0456-2","volume":"18","author":"P Bose","year":"2017","unstructured":"Bose P, Vachhani P, Cortes JE. Treatment of Relapsed\/Refractory Acute Myeloid Leukemia. Curr Treat Options Oncol. 2017;18(3):17.","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"3372_CR75","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41419-019-1851-3","volume":"10","author":"SB Panina","year":"2019","unstructured":"Panina SB, Baran N, Brasil da Costa FH, Konopleva M, Kirienko NV. A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs. Cell Death Dis. 2019;10(8):617.","journal-title":"Cell Death Dis"},{"key":"3372_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00435","volume":"10","author":"SB Panina","year":"2020","unstructured":"Panina SB, Pei J, Baran N, Konopleva M, Kirienko NV. Utilizing synergistic potential of mitochondria-targeting drugs for leukemia therapy. Front Oncol. 2020;10: 435.","journal-title":"Front Oncol"},{"issue":"4","key":"3372_CR77","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41375-023-01835-x","volume":"37","author":"C Larrue","year":"2023","unstructured":"Larrue C, Mouche S, Lin S, Simonetta F, Scheidegger NK, Poulain L, Birsen R, Sarry JE, Stegmaier K, Tamburini J. Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia. Leukemia. 2023;37(4):765\u201375.","journal-title":"Leukemia"},{"issue":"19","key":"3372_CR78","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1074\/jbc.RA119.010983","volume":"295","author":"H Lee","year":"2020","unstructured":"Lee H, Smith SB, Sheu SS, Yoon Y. The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress. J Biol Chem. 2020;295(19):6543\u201360.","journal-title":"J Biol Chem"},{"issue":"6","key":"3372_CR79","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tice.2010.10.004","volume":"42","author":"C Ulivieri","year":"2010","unstructured":"Ulivieri C. Cell death: insights into the ultrastructure of mitochondria. Tissue Cell. 2010;42(6):339\u201347.","journal-title":"Tissue Cell"},{"key":"3372_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1124678","volume":"10","author":"F Lengauer","year":"2023","unstructured":"Lengauer F, Geisslinger F, Gabriel A, von Schwarzenberg K, Vollmar AM, Bartel K. A metabolic shift toward glycolysis enables cancer cells to maintain survival upon concomitant glutamine deprivation and V-ATPase inhibition. Front Nutr. 2023;10: 1124678.","journal-title":"Front Nutr"},{"issue":"9","key":"3372_CR81","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1182\/blood.V79.9.2378.2378","volume":"79","author":"K Sugimoto","year":"1992","unstructured":"Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Ishikawa F, Takaku F, Yazaki Y, Hirai H. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood. 1992;79(9):2378\u201383.","journal-title":"Blood"},{"issue":"12","key":"3372_CR82","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.3390\/cancers15123210","volume":"15","author":"D Zhao","year":"2023","unstructured":"Zhao D, Zarif M, Zhou Q, Capo-Chichi JM, Schuh A, Minden MD, Atenafu EG, Kumar R, Chang H. TP53 mutations in AML patients are associated with dismal clinical outcome irrespective of frontline induction regimen and allogeneic hematopoietic cell transplantation. Cancers (Basel). 2023;15(12):3210.","journal-title":"Cancers (Basel)"},{"issue":"5660","key":"3372_CR83","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1092734","volume":"303","author":"JE Chipuk","year":"2004","unstructured":"Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303(5660):1010\u20134.","journal-title":"Science"},{"issue":"1","key":"3372_CR84","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1152\/physiolgenomics.90346.2008","volume":"37","author":"A Saleem","year":"2009","unstructured":"Saleem A, Adhihetty PJ, Hood DA. Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle. Physiol Genomics. 2009;37(1):58\u201366.","journal-title":"Physiol Genomics"},{"issue":"16","key":"3372_CR85","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1073\/pnas.1002459107","volume":"107","author":"S Suzuki","year":"2010","unstructured":"Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y, et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A. 2010;107(16):7461\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5741","key":"3372_CR86","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1126\/science.1114297","volume":"309","author":"JE Chipuk","year":"2005","unstructured":"Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science. 2005;309(5741):1732\u20135.","journal-title":"Science"},{"issue":"7","key":"3372_CR87","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1158\/0008-5472.CAN-03-0846","volume":"64","author":"F Schwartzenberg-Bar-Yoseph","year":"2004","unstructured":"Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004;64(7):2627\u201333.","journal-title":"Cancer Res"},{"issue":"1","key":"3372_CR88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","volume":"126","author":"K Bensaad","year":"2006","unstructured":"Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 2006;126(1):107\u201320.","journal-title":"Cell"},{"issue":"4","key":"3372_CR89","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1947601911409738","volume":"2","author":"AM Puzio-Kuter","year":"2011","unstructured":"Puzio-Kuter AM. The Role of p53 in Metabolic Regulation. Genes Cancer. 2011;2(4):385\u201391.","journal-title":"Genes Cancer"},{"issue":"21","key":"3372_CR90","first-page":"2003","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2013;8(21):2003\u201314.","journal-title":"Neural Regen Res"},{"issue":"2","key":"3372_CR91","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1550-2783-2-2-38","volume":"2","author":"C Kerksick","year":"2005","unstructured":"Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr. 2005;2(2):38\u201344.","journal-title":"J Int Soc Sports Nutr"},{"issue":"5","key":"3372_CR92","doi-asserted-by":"publisher","first-page":"a026070","DOI":"10.1101\/cshperspect.a026070","volume":"6","author":"AB Williams","year":"2016","unstructured":"Williams AB, Schumacher B. p53 in the DNA-Damage-Repair process. Cold Spring Harb Perspect Med. 2016;6(5):a026070.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"3372_CR93","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1083\/jcb.201009059","volume":"192","author":"PA Muller","year":"2011","unstructured":"Muller PA, Vousden KH, Norman JC. p53 and its mutants in tumor cell migration and invasion. J Cell Biol. 2011;192(2):209\u201318.","journal-title":"J Cell Biol"},{"key":"3372_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.637064","volume":"9","author":"Y Luo","year":"2021","unstructured":"Luo Y, Lu Y, Long B, Lin Y, Yang Y, Xu Y, Zhang X, Zhang J. Blocking DNA Damage Repair May Be Involved in Stattic (STAT3 Inhibitor)-Induced FLT3-ITD AML Cell Apoptosis. Front Cell Dev Biol. 2021;9: 637064.","journal-title":"Front Cell Dev Biol"},{"key":"3372_CR95","doi-asserted-by":"crossref","unstructured":"Alkhatabi HA, Zohny SF, Shait Mohammed MR, Choudhry H, Rehan M, Ahmad A, Ahmed F, Khan MI. Venetoclax-resistant MV4\u201311 leukemic cells activate PI3K\/AKT pathway for metabolic reprogramming and redox adaptation for survival. Antioxidants (Basel). 2022;11(3):461.","DOI":"10.3390\/antiox11030461"},{"issue":"1","key":"3372_CR96","first-page":"17","volume":"39","author":"X You","year":"2019","unstructured":"You X, Jiang W, Lu W, Zhang H, Yu T, Tian J, Wen S, Garcia-Manero G, Huang P, Hu Y. Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis. Cancer Commun (Lond). 2019;39(1):17.","journal-title":"Cancer Commun (Lond)"},{"issue":"7","key":"3372_CR97","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.biochi.2006.02.001","volume":"88","author":"ES Yang","year":"2006","unstructured":"Yang ES, Park JW. Antioxidant enzyme inhibitors enhance nitric oxide-induced cell death in U937 cells. Biochimie. 2006;88(7):869\u201378.","journal-title":"Biochimie"},{"issue":"1","key":"3372_CR98","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1096\/fj.02-0105fje","volume":"17","author":"G Filomeni","year":"2003","unstructured":"Filomeni G, Rotilio G, Ciriolo MR. Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 MAP kinase pathway. FASEB J. 2003;17(1):64\u20136.","journal-title":"FASEB J"},{"issue":"11","key":"3372_CR99","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1158\/1078-0432.CCR-16-1903","volume":"23","author":"JE Jang","year":"2017","unstructured":"Jang JE, Eom JI, Jeung HK, Cheong JW, Lee JY, Kim JS, Min YH. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells. Clin Cancer Res. 2017;23(11):2781\u201394.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3372_CR100","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3892\/ol.2012.931","volume":"4","author":"O Zitka","year":"2012","unstructured":"Zitka O, Skalickova S, Gumulec J, Masarik M, Adam V, Hubalek J, Trnkova L, Kruseova J, Eckschlager T, Kizek R. Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol Lett. 2012;4(6):1247\u201353.","journal-title":"Oncol Lett"},{"issue":"13","key":"3372_CR101","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2210796120","volume":"120","author":"D Huang","year":"2023","unstructured":"Huang D, Zhang C, Xiao M, Li X, Chen W, Jiang Y, Yuan Y, Zhang Y, Zou Y, Deng L, et al. Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells. Proc Natl Acad Sci U S A. 2023;120(13): e2210796120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"3372_CR102","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/cdd.2009.107","volume":"16","author":"R Franco","year":"2009","unstructured":"Franco R, Cidlowski JA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ. 2009;16(10):1303\u201314.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3372_CR103","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3372_CR104","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/ars.2017.7216","volume":"28","author":"W Xiao","year":"2018","unstructured":"Xiao W, Wang RS, Handy DE, Loscalzo J. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. Antioxid Redox Signal. 2018;28(3):251\u201372.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"3372_CR105","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/pgs-2016-0150","volume":"18","author":"S Varatharajan","year":"2017","unstructured":"Varatharajan S, Abraham A, Karathedath S, Ganesan S, Lakshmi KM, Arthur N, Srivastava VM, George B, Srivastava A, Mathews V, et al. ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers. Pharmacogenomics. 2017;18(3):235\u201344.","journal-title":"Pharmacogenomics"},{"issue":"6","key":"3372_CR106","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1182\/bloodadvances.2018022921","volume":"3","author":"YT Chang","year":"2019","unstructured":"Chang YT, Hernandez D, Alonso S, Gao M, Su M, Ghiaur G, Levis MJ, Jones RJ. Role of CYP3A4 in bone marrow microenvironment-mediated protection of FLT3\/ITD AML from tyrosine kinase inhibitors. Blood Adv. 2019;3(6):908\u201316.","journal-title":"Blood Adv"},{"key":"3372_CR107","doi-asserted-by":"crossref","unstructured":"Gillespie MS, Ward CM, Davies CC. DNA repair and therapeutic strategies in cancer stem cells. Cancers (Basel). 2023;15(6):1897.","DOI":"10.3390\/cancers15061897"},{"issue":"Pt B","key":"3372_CR108","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","volume":"88","author":"LE Tebay","year":"2015","unstructured":"Tebay LE, Robertson H, Durant ST, Vitale SR, Penning TM, Dinkova-Kostova AT, Hayes JD. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 2015;88(Pt B):108\u201346.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"3372_CR109","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. 2015;373(12):1136\u201352.","journal-title":"N Engl J Med"},{"key":"3372_CR110","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/943823","volume":"2010","author":"LD Eleni","year":"2010","unstructured":"Eleni LD, Nicholas ZC, Alexandros S. Challenges in treating older patients with acute myeloid leukemia. J Oncol. 2010;2010: 943823.","journal-title":"J Oncol"},{"issue":"18","key":"3372_CR111","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","volume":"381","author":"AE Perl","year":"2019","unstructured":"Perl AE, Martinelli G, Cortes JE, Neubauer A, Berman E, Paolini S, Montesinos P, Baer MR, Larson RA, Ustun C, et al. Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML. N Engl J Med. 2019;381(18):1728\u201340.","journal-title":"N Engl J Med"},{"issue":"2","key":"3372_CR112","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41375-020-01069-1","volume":"35","author":"R Nair","year":"2021","unstructured":"Nair R, Salinas-Illarena A, Baldauf HM. New strategies to treat AML: novel insights into AML survival pathways and combination therapies. Leukemia. 2021;35(2):299\u2013311.","journal-title":"Leukemia"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03372-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03372-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03372-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:05:36Z","timestamp":1744149936000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03372-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3372"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03372-0","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Seoul National University Institutional Animal Care and Use Committee (SNU-220704\u20136-3) and performed in accordance with the guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}